Skip to main content
. 2020 Oct 20;21(20):7767. doi: 10.3390/ijms21207767

Table A2.

Patient #2 laboratory findings.

Pt#2 ESR mm/h IS CRP mg/L WBC/μL HB g/dL PLT/μL IgG mg/dL IgA mg/dL
Before JAKinhibs 27 29.1 1.7 5700 11.1 195,000 1645 399
After JAKinhibs 46 1.0 0.2 5110 12.4 337,000 1538 368
Last FUP 22 3.0 0.2 5400 12.9 252,000 1752 314